XML 39 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Compensatory Equity Incentive Plan and Other Equity Incentives (Tables)
3 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of share based compensation award plans

These plans are summarized below:

 

   Award   Award Shares
Outstanding
at September 30,
   Available for
Issuance
at September 30,
 
Equity Compensation Arrangement  Authorized   2017   2017 
Amended and Restated Omnibus Incentive Plan   3,915,625    2,598,218    637,290 
Employee Stock Purchase Plan   400,000        370,895 
    4,315,625    2,598,218    1,008,185 

 

Schedule of share-based payment awards activity

A summary of the activity for share-based compensation awards in the three months ended September 30, 2017 is presented below:

  

   Stock Options   Restricted
Stock Units (RSUs)
 
   Shares   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contract
   Shares   Weighted
Average
Remaining
Contract
 
June 30, 2017   1,096,186   $1.68    6.3    1,508,782    0.9 
                          
Granted                    
Exercised                    
Cancelled/Forfeited   (6,750)  $3.01             
                          
September 30, 2017   1,089,436   $1.67    6.1    1,508,782    0.9 
                          
Awards exercisable/                         
vested as of                         
September 30, 2017   848,675   $1.69    5.5    1,069,870     
                          
Awards unexercisable/                         
unvested as of                         
September 30, 2017   240,761   $1.60    8.4    438,912    0.9 
    1,089,436              1,508,782      

 

Schedule of share-based compensation future cost to be recognized

We expect to recognize the compensation cost as follows:

              
    Stock
Options
   RSUs   Total 
Nine months ended June 30, 2018    26,566    165,025    191,591 
                 
Year ended June 30, 2019    18,083    144,984    163,067 
                 
Year ended June 30, 2020    4,276    29,989    34,265 
                 
Year ended June 30, 2021    2,105        2,105 
    $51,030   $339,998   $391,028 

 

Summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards

The following table is a summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards as of September 30, 2017 and changes during the three months then ended:

 

Unexercisable/unvested awards  Stock
Options
Shares
   RSU Shares   Total
Shares
   Weighted-Average
Grant Date Fair Values
(per share)
 
                 
June 30, 2017   244,511    438,912    683,423   $1.39 
                     
Granted                
                     
Vested                
                     
Cancelled/Forfeited   (3,750)       (3,750)  $1.39 
September 30, 2017   240,761    438,912    679,673   $1.39 

 

Schedule of total stock-based compensation expense included in the consolidated statements of comprehensive income

The following table shows total stock-based compensation expense for the three months ended September 30, 2017 and 2016 included in the consolidated statements of comprehensive income:

 

   Three months ended September 30, 
   2017   2016 
         
Stock options  $12,348   $11,672 
RSUs   79,893    108,268 
Total  $92,241   $119,940 
           
The amounts above were included in:          
Selling, general & administrative  $90,274   $119,576 
Cost of sales   1,603    79 
New product development   364    285 
   $92,241   $119,940